Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
article
OA: closed
CC0
⤵ 220 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Prostaglandin E2 was found to stimulate aromatase expression in endometriosis-derived stromal cells, contributing to estrogen production in the endometriotic tissue.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (50)
- Exploring the therapeutic potential of H1-antihistamines in endometriosis—A gene regulation-based perspective 2025
- Molecular Profile (Estrogen Receptor, Progesterone Receptor, Bcl-2 and Ki-67) of the Ectopic Endometrium in Patients with Endometriosis 2025
- Neurotrimin, a neural adhesion molecule, expression in early and advanced stage endometriosis 2025
- Endometriosis and ovulatory menstruation: beyond the Sampson principle 2025
- How to Protect Fertility Potential in Endometriosis 2024
- Endometriosis: Pathogenesis, Diagnosis and Treatment, volume II 2024
- Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases 2024
- The “Road” to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review 2024
- Hormonal Therapies before in vitro fertilization in women with endometriosis: The Minotaur's Labyrinth and the Ariadne's Thread 2024
- Luoshi Neiyi Prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway 2024
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- Genomic Insults and their Redressal in the Eutopic Endometrium of Women with Endometriosis 2023
- Therapeutic effects of melatonin on endometriosis, targeting molecular pathways: Current knowledge and future perspective 2023
- Which endometrial preparation protocol provides better pregnancy and perinatal outcomes for endometriosis patients in frozen-thawed embryo transfer cycles? A retrospective study on 1413 patients 2023
- Chronic Pelvic Pain, Vulvar Pain Disorders, and Proteomics Profiles: New Discoveries, New Hopes 2023
- Network pharmacology and experimental validation to explore the potential mechanism of Sanjie Zhentong Capsule in endometriosis treatment 2023
- Quality of life of patients with bilateral oophorectomy before the age of 45 for the treatment of endometriosis 2022
- Endometriosis Research: From Bench to Bedside 2022
- The Effect of Ulipristal Acetate on Surgical Endometriosis Created in Rats 2022
- Pathogenesis of Endometriosis: Role of Platelets in Endometriosis 2022
- Metformin as a Potential Treatment Option for Endometriosis 2022
- Epigenetic Factors in Eutopic Endometrium in Women with Endometriosis and Infertility 2022
- Endocrine disruptor hexachlorobenzene induces cell migration and invasion, and enhances aromatase expression levels in human endometrial stromal cells 2022
- Aberrant epigenetic regulation of estrogen and progesterone signaling at the level of endometrial/endometriotic tissue in the pathomechanism of endometriosis 2022
- Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism 2022
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Endometrioma mimicking ovarian malignancy in a post-menopausal woman 2021
- Elagolix Sodium: Novel GnRH Antagonist for the Treatment of Endometriosis 2021
- Progestogens and Endometriosis 2021
- Placenta Previa Complicated with Endometriosis: Contemporary Clinical Management, Molecular Mechanisms, and Future Research Opportunities 2021
- Immune phenotypes and mediators affecting endometrial function in women with endometriosis 2021
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
- Evaluation of the effect of aromatase inhibitor in reducing the size of endometrioma 2021
- Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis 2021
- Lipoxin A4 inhibits the development of endometriosis in a mouse model by suppressing local estradiol synthesis 2020
- Epithelial Cells in Endometriosis and Adenomyosis Upregulate STING Expression 2020
- Endometriosis Cell Proliferation Induced by Bone Marrow Mesenchymal Stem Cells 2020
- Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis 2020
- Molecular profile of eutopic and ectopic endometrium in endometriosis 2020
- Establishment of an Immortalized Endometriotic Stromal Cell Line from Human Ovarian Endometrioma 2020
- Endometriosis 2019
- The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights 2019
- Endometriosis 2019
- Hypoxia: The force of endometriosis 2019
- Local estrogen formation and its regulation in endometriosis 2019
- Endometriosis and nuclear receptors 2019
- An assessment of the multifactorial profile of steroid-metabolizing enzymes and steroid receptors in the eutopic endometrium during moderate to severe ovarian endometriosis 2019
- Increased circulating miR-370-3p regulates steroidogenic factor 1 in endometriosis 2018
- Aromatase as a target for treating endometriosis 2018
- Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders 2018
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK